Brian S. Robins

Brian Robins joined DavosPharma in 1994. He focused on a number of multinational and emerging pharmaceutical companies, developing six clinical candidates. Three of these NCE projects are in late Phase III clinical trials, and one is awaiting FDA approval. Prior to joining DavosPharma, Mr. Robins worked at Delmar Chemical in Montreal. Mr. Robins holds a B.Sc. in Chemical Engineering from Queen’s University, Kingston, Ontario.